Oligomerix has received a $1.
Author: Michael
Cambrian Bio presented Phase 1b human translation
NorthStrive Biosciences, a PMGC Holdings Inc.
Designs for Health launched Akkermansia Pro GLP-1
BPGbio presented clinical and translational findi
A once-daily patch could make one of pulmonary a
New data suggest MS 001 could help preserve musc
LNS8801 advances into the National Institute on
Dan DeBaun, founder of the largest authorized Be
A one-time CRISPR treatment dramatically reduced